Deep belly fat could predict Alzheimer's disease

‘Hidden’ fat could predict Alzheimer’s disease up to 20 years before symptoms, research finds
In the latest Alzheimer’s research, hidden fat in various parts of the body was shown to be an early warning sign of the common dementia — as long as 20 years prior to symptoms emerging.
How one health concern could predict Alzheimer’s disease decades before first symptoms occur
The physicians tied a specific type of body fat, known as visceral fat, to higher levels of abnormal proteins in the brain that are indicators of Alzheimer’s. Visceral fat builds up around and between internal organs and can increase the risk of serious health issues. It is different than subcutaneous fat, which is fat just below the skin.
Deep belly fat could predict Alzheimer's disease decades ahead of symptoms
People who are obese and harbor deep belly fat are at higher risk for developing Alzheimer's disease-specific proteins in the brain up to 20 years before the earliest dementia symptoms, a new study suggests.
Body fat could hold key to predicting Alzheimer’s disease decades before symptoms arise
One study found visceral fat levels were closely linked to higher levels of amyloid plaque in the brain, a protein that is considered a hallmark sign of Alzheimer’s disease. The second study observed reduced blood flow to the brain in people with elevated levels of visceral tissue.
Belly fat could trigger Alzheimer’s 20 years before symptoms show, study suggests
Excessive belly fat may start causing Alzheimer’s disease 20 years before symptoms emerge, new research suggests.
Sex differences in neuron protection could reveal Alzheimer's target
Inhibiting TLR7, an immune signaling protein, may help preserve the protective layer surrounding nerve fibers in the brain ...
Medpage Today on MSN15h
Case Study: The Unexpected Benefits of Physiotherapy in a Patient With Alzheimer's Disease
Each episode of this journey through a disease state contains both a physician guide and a downloadable/printable patient ...
earth2d
Study declaring Alzheimer's to be a "brain disease" proven to be fabricated
New theories suggest Alzheimer's may involve autoimmunity, with beta-amyloid linked to immune response misfires.
Novel all-in-one computational pipeline offers insights into Alzheimer's mechanisms and potential drug targets
Researchers at Columbia University Mailman School of Public Health have developed a novel computational pipeline designed to ...
Blocking key enzyme could reverse Alzheimer’s disease, study finds
The brain cells, or neurons, also showed signs of recovery, the scientists reported in Nature Neuroscience. This discovery ...
News Medical on MSN17h
Behavioral chaos in Alzheimer’s disease mice decoded by machine learning
Researchers use machine learning to identify behavioral disruptions in Alzheimer’s disease mouse models, highlighting a ...
Neuroscience News6h
Study Links Muscle Loss to Alzheimer’s Risk
New research shows that skeletal muscle loss, measured through temporalis muscle size on brain MRIs, is associated with a ...
BioWorld2h
Switch Therapeutics nominates liver-sparing APOE RNAi therapy as development candidate for Alzheimer’s
Switch Therapeutics Inc. has announced its first development candidate, a liver-sparing APOE (apolipoprotein E) RNAi therapy for treatment of Alzheimer’s disease in APOE4 carriers. Switch’s ...
Senate passes bill to expand Alzheimer’s prevention efforts
The U.S. Senate recently passed the Building Our Largest Dementia (BOLD) Infrastructure for Alzheimer’s Reauthorization Act ...